Neurocrine Biosciences announces presentation of Osavampator Phase 2 data at Psych Congress 2025

Ascletis presents ASC30 study results at EASD Annual Meeting

Three WuXi Biologics manufacturing facilities receive GMP certification from Turkish regulator

VarmX secures strategic collaboration and option agreement with CSL for novel coagulation therapy

Made Scientific and Basilard BioTech partner on advancing ex vivo gene delivery for T cell and iPSC therapies

Avidity Biosciences closes USD690m public offering of common stock

Akeso's ligufalimab (CD47 mAb) granted FDA Orphan Drug Designation for AML

Forte Biosciences highlights positive FB102 data in celiac disease at Tampere Symposium

SureSpace Launches in Dubai to Tackle Doomscrolling and Redefine Social Networking

Kodiak reports positive APEX data for KSI-101 in macular edema secondary to inflammation

Biophytis secures Brazilian funding and partnerships for obesity Phase 2 trial

Phrontline Biopharma doses first patient in TJ101 Phase 1 clinical trial

Gene Solutions' mitochondrial therapy platform targeting neurological diseases secures patent

Zhimeng Biopharma's investigational drug gains Phase 2 epilepsy clinical trial approval in China

Avidity Biosciences prices upsized common stock public offering